Etidocaine
Clinical data | |
---|---|
Trade names | Duranest |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a603026 |
Pregnancy category |
|
Parenteral | |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | n/a |
Metabolism | Hepatic |
Elimination half-life | 2.5 hours |
Excretion | Renal |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Etidocaine, marketed under the trade name Duranest, is an amide-type local anesthetic given by injection during surgical procedures and labor and delivery. Etidocaine has a long duration of activity, and the main disadvantage of using during dentistry is increased bleeding during surgery.[1]
Synthesis
The amide reaction between
2,6-xylidine
(1) and 2-bromobutyryl chloride [22118-12-3] (2) gives 2-Bromo-N-(2,6-Dimethylphenyl)Butanamide [53984-81-9] (3). Alkylation with N-Ethylpropylamine [20193-20-8] (4) gives Etidocaine (5).
References
- PMID 1308373.
- ^ DE2162744 idem H Adams, G Kronberg, B Takman, U.S. patent 3,812,147 (1974 to Astra Pharma Prod).
- ^ Org. Synth. 1950, 30, 62. DOI: 10.15227/orgsyn.030.0062
External links
- Duranest (RxList)